Oral co-supplementation of curcumin, quercetin, and vitamin d3 as an adjuvant therapy for mild to moderate symptoms of covid-19 — results from a pilot open-label, randomized controlled trial

HIGHLIGHTS

• who: Curcumin et al. from the Malaysia Old Dominion University have published the research: Oral Co-Supplementation of Curcumin, Quercetin, and Vitamin D3 as an Adjuvant Therapy for Mild to Moderate Symptoms of COVID-19 u2014 Results From a Pilot Open-Label, Randomized Controlled Trial, in the Journal: (JOURNAL) of 28/Nov/2021
• what: The authors conducted a pilot open-label, randomized controlled clinical trial to assess the possible treatment benefits of an oral formulation containing CQC supplements as an add-on to routine care in mild to moderately symptomatic COVID-19 outpatients. The study . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.